Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments


News provided by

XRP HEALTHCARE LIMITED

22 Dec, 2025, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment infrastructure

DUBAI, UAE, Dec. 22, 2025 /PRNewswire/ -- XRP Healthcare today announced the continued expansion of its XRP Healthcare® trademark portfolio, securing protection across healthcare services, digital health technology, and payment-related infrastructure in multiple global jurisdictions.

The XRP Healthcare® trademark is registered in the United States under Classes 9 and 44, with established registrations in the United Kingdom, European Union, United Arab Emirates, and Uganda, and additional jurisdictions currently in process as part of the company's ongoing international trademark strategy.

The trademark registrations in the United Kingdom, European Union, United Arab Emirates, and Uganda were secured and announced over the past two years as part of a phased, jurisdiction-by-jurisdiction approach. These earlier registrations established foundational protection across key healthcare and emerging markets. The recent United States registrations under Classes 9 and 44 further strengthen this framework, completing a multi-market trademark perimeter aligned with healthcare services, digital health, and XRP-powered payment infrastructure.

The dual U.S. trademark coverage provides integrated protection spanning digital health platforms and healthcare software infrastructure, virtual healthcare payment use cases leveraging XRP-based settlement infrastructure, and pharmacy services and healthcare delivery models. This legal framework underpins XRP Healthcare's operating model at the convergence of healthcare and payments while reducing brand and execution risk.

XRP Healthcare already operates a live Prescription Savings Card program in the United States, accepted at approximately 68,000 pharmacies nationwide and in continuous use since March 2022. This established footprint demonstrates real-world integration within the U.S. healthcare ecosystem and provides a practical distribution foundation for broader digital payment and healthcare initiatives.

The XRP Healthcare® trademark is owned by a related IP holding entity and licensed to the group's operating companies, including XRP Healthcare LLC, which focuses on healthcare payment infrastructure, wallet technology, and ecosystem tools, and XRP Healthcare M&A Holding Inc., which focuses on healthcare acquisitions, pharmacy networks, AI-enabled healthcare services, and international expansion.

As part of its ecosystem, XRP Healthcare operates the XRPH Wallet, an open-source, non-custodial, XRPL-native payment wallet designed for healthcare-related payment workflows. The wallet does not store or transmit protected health information, follows a HIPAA-grade standard architecture (design-led, not regulatory certification), and supports XRP, XRPH, and RLUSD. Healthcare providers and pharmacies may deploy the XRPH Wallet directly or build their own compliant payment solutions using XRP Healthcare's open-source framework.

XRP Healthcare's acquisition and expansion strategy is being executed through XRP Healthcare M&A Holding Inc., which is pursuing a proposed public listing on the TSX Venture Exchange (TSXV) in Canada, subject to regulatory review, market conditions, and customary approvals.

As part of its capital-markets preparation, XRP Healthcare M&A Holding Inc. has engaged experienced capital-markets advisors, including ARC Group, in shaping its public-market structure, governance framework, and transaction readiness. Advisory input has included guidance from ARC Group leadership, including its founder Abraham Cinta, alongside senior advisors such as Charles Chong. These advisory engagements are non-controlling and do not constitute sponsorship, underwriting, or funding commitments.

By securing trademark protection across healthcare services and digital payment infrastructure, XRP Healthcare has established a framework that supports future payment-rail participation, integrations, partnerships, and licensing opportunities aligned with compliant healthcare payment use cases, including pharmacy and provider workflows in the United States and Africa.

About XRP Healthcare

XRP Healthcare is building a global healthcare platform spanning digital payment infrastructure, AI-enabled healthcare tools, and physical healthcare operations, with a focus on compliant architecture, institutional alignment, and sustainable value creation.

For more information, visit: https://www.xrphealthcare.ai, explore the XRP Healthcare ecosystem at www.xrphtoken.com, or follow XRP Healthcare on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements regarding proposed capital-markets activities, planned expansions, anticipated partnerships, healthcare acquisitions, payment-infrastructure development, licensing opportunities, and the potential public listing of XRP Healthcare M&A Holding Inc. on the TSX Venture Exchange.

Forward-looking statements are based on current expectations, assumptions, and estimates and are subject to a number of risks, uncertainties, and other factors that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, regulatory approvals, market conditions, availability of financing, operational execution, and changes in economic or industry conditions. Readers are cautioned not to place undue reliance on forward-looking statements. XRP Healthcare and its affiliated entities undertake no obligation to update or revise forward-looking statements except as required by applicable law.

Contact
Kain Roomes
Founder & CEO
Direct: +971 50 401 0662
www.xrphealthcare.ai 

Photo: https://mma.prnewswire.com/media/2850075/XRP_Healthcare.jpg
Logo: https://mma.prnewswire.com/media/2365357/5691929/XRP_Healthcare_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.